Association between antecedent intravenous antimicrobial exposure and isolation of vancomycin-resistant enterococci.

Chavers, L S; Moser, S A; Funkhouser, E; Benjamin, W H; Chavers, P; Stamm, A M; Waites, K B

Chavers, L S; Moser, S A; Funkhouser, E; Benjamin, W H; Chavers, P; Stamm, A M; Waites, K B.

Affiliation

Chavers LS; Department of Epidemiology and International Health, University of Alabama at Birmingham, Birmingham, AL 35249, USA.

Microb Drug Resist ; 9 Suppl 1: S69-77, 2003.

Article in En | MEDLINE | ID: mdl-14633370

Subject(s)

Anti-Bacterial Agents/administration & dosage; Anti-Bacterial Agents/therapeutic use; Enterococcus/isolation & purification; Vancomycin Resistance; Adult; Aged; Case-Control Studies; Ceftazidime/administration & dosage; Ceftazidime/therapeutic use; Cross Infection/microbiology; Cross Infection/prevention & control; Enterococcus/drug effects; Female; Gram-Positive Bacterial Infections/microbiology; Gram-Positive Bacterial Infections/prevention & control; Hospitals, Urban; Humans; Imipenem/administration & dosage; Imipenem/therapeutic use; Infusions, Intravenous; Male; Middle Aged; Severity of Illness Index; Vancomycin/pharmacology

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Enterococcus / Vancomycin Resistance / Anti-Bacterial Agents Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Microb Drug Resist Journal subject: MICROBIOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2003 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links